Spectrum Planning & Advisory Services Inc. Vascular Biogenics Ltd. Transaction History

Spectrum Planning & Advisory Services Inc.

  • $101 Million
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 17, 2022
BUY
$0.15 - $2.1 $2,400 - $33,600
16,000 New
16,000 $2,000
Q2 2022

Jul 15, 2022
SELL
$1.22 - $1.95 $19,520 - $31,200
-16,000 Closed
0 $0
Q4 2021

Jan 19, 2022
BUY
$1.92 - $2.53 $30,720 - $40,480
16,000 New
16,000 $32,000

Others Institutions Holding VBLT

# of Institutions
2
Shares Held
416K
Call Options Held
0
Put Options Held
0
View Full List

About Vascular Biogenics Ltd.

VBLT Quotes by TradingView
  • Ticker VBLT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,348,896
  • Description
  • Vascular Biogenics Ltd., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of cancer and immune-inflammatory diseases in Israel and the United States. Its programs are based on its vascular targeting system, a gene-based technology targeting newly formed blood vessels; and monocyte targeting technology, an antib...
More about VBLT
Track This Portfolio

Track Spectrum Planning & Advisory Services Inc. Portfolio

Follow Spectrum Planning & Advisory Services Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Spectrum Planning & Advisory Services Inc., based on Form 13F filings with the SEC.

News

Stay updated on Spectrum Planning & Advisory Services Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email